Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects.

Min Zhou, Jing Yu, Xuewei Li, Zheng Ruan, Shaohui Yu
Author Information
  1. Min Zhou: Department of Gynaecology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
  2. Jing Yu: Department of Endocrinology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
  3. Xuewei Li: Department of Gynaecology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
  4. Zheng Ruan: Department of Traditional Chinese Medicine, 964th Hospital, Changchun, China.
  5. Shaohui Yu: Department of Gynaecology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China. ORCID

Abstract

Polycystic ovary syndrome (PCOS) is one of the modern intractable reproductive diseases. The female irregular menstruation, infertility, obesity, and so forth caused by PCOS have become a hot issue affecting family harmony and social development. The aetiology of PCOS is complex. In recent years, many scholars have found that its pathogenesis was related to the imbalance of gut microbiota. Gut microbiota can form two-way communication with the brain through the 'gut-brain axis' and affect the host's metabolism. Current research has confirmed that the gut microbiota can interfere with glucose and lipid metabolism, insulin sensitivity, hormone secretion and follicular development in women by altering intestinal mucosal permeability and secreting metabolites. In addition, the diversity and composition of gut microbiota of PCOS patients changed, which may affect the metabolic function of the gut microbiota and the ability to produce metabolites, and may also directly or indirectly affect the endocrine function. This study reviewed recent research advances about the role of gut microbiota in PCOS. In order to provide basis for prevention and treatment of PCOS based on gut microbiota.

Keywords

References

  1. PLoS One. 2016 Jan 05;11(1):e0146509 [PMID: 26731268]
  2. Gut Microbes. 2021 Jan-Dec;13(1):1-21 [PMID: 33722164]
  3. Gastroenterology. 2019 Apr;156(5):1324-1332.e3 [PMID: 30610862]
  4. Health Sci Rep. 2020 Dec 04;3(4):e212 [PMID: 33305014]
  5. mSystems. 2022 Jun 28;7(3):e0027322 [PMID: 35675542]
  6. Med Hypotheses. 2012 Jul;79(1):104-12 [PMID: 22543078]
  7. Oncotarget. 2016 Aug 30;7(35):56071-56082 [PMID: 27528227]
  8. PLoS One. 2016 Apr 19;11(4):e0153196 [PMID: 27093642]
  9. Endocr J. 2019 Oct 28;66(10):859-870 [PMID: 31270279]
  10. Front Cell Infect Microbiol. 2021 Sep 30;11:702628 [PMID: 34660336]
  11. Nat Rev Endocrinol. 2018 May;14(5):270-284 [PMID: 29569621]
  12. Gut Microbes. 2022 Jan-Dec;14(1):2100197 [PMID: 35854629]
  13. Eur J Nutr. 2020 Mar;59(2):433-450 [PMID: 31256251]
  14. J Am Coll Nutr. 2020 May-Jun;39(4):371-382 [PMID: 31513473]
  15. J Clin Endocrinol Metab. 2019 Mar 1;104(3):934-946 [PMID: 30590569]
  16. Front Cell Infect Microbiol. 2023 Feb 24;13:1142041 [PMID: 36909735]
  17. Front Endocrinol (Lausanne). 2022 Jul 19;13:933110 [PMID: 35928893]
  18. J Agric Food Chem. 2023 Feb 14;: [PMID: 36786768]
  19. Clin Chim Acta. 2020 Apr;503:90-98 [PMID: 31968211]
  20. Food Funct. 2020 Jun 24;11(6):5192-5204 [PMID: 32441726]
  21. Gut. 2016 Mar;65(3):365-7 [PMID: 26531718]
  22. J Formos Med Assoc. 2019 Mar;118 Suppl 1:S23-S31 [PMID: 30181015]
  23. Cytokine. 2008 May;42(2):145-151 [PMID: 18304834]
  24. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1502-1511 [PMID: 29370410]
  25. J Allergy Clin Immunol. 2020 Nov;146(5):1165-1179.e11 [PMID: 32311393]
  26. Front Cell Infect Microbiol. 2021 Mar 17;11:625913 [PMID: 33816335]
  27. Nutrients. 2017 Dec 12;9(12): [PMID: 29231905]
  28. Nat Med. 2019 Sep;25(9):1459 [PMID: 31471570]
  29. Front Endocrinol (Lausanne). 2020 Sep 08;11:628 [PMID: 33013704]
  30. Front Endocrinol (Lausanne). 2020 Aug 11;11:516 [PMID: 32849300]
  31. Metabolites. 2023 May 31;13(6): [PMID: 37367875]
  32. J Endocrinol Invest. 2021 Aug;44(8):1727-1737 [PMID: 33387350]
  33. Ann Nutr Metab. 2021;77(6):313-323 [PMID: 34610596]
  34. Biosci Trends. 2019 Jan 22;12(6):526-536 [PMID: 30606977]
  35. J Cell Mol Med. 2024 Apr;28(8):e18258 [PMID: 38546608]
  36. Front Endocrinol (Lausanne). 2021 Nov 11;12:747888 [PMID: 34858330]
  37. Nutrients. 2022 Jan 10;14(2): [PMID: 35057459]
  38. Fertil Steril. 2016 Jul;106(1):6-15 [PMID: 27233760]
  39. EBioMedicine. 2020 Jan;51:102590 [PMID: 31901868]
  40. Nat Rev Endocrinol. 2011 Apr;7(4):219-31 [PMID: 21263450]
  41. Cell Rep. 2022 Nov 22;41(8):111681 [PMID: 36417859]
  42. Med Hypotheses. 2021 Sep;154:110644 [PMID: 34332209]
  43. Appl Physiol Nutr Metab. 2015 Jul;40(7):749-52 [PMID: 25962839]
  44. Food Funct. 2022 Oct 3;13(19):9878-9892 [PMID: 36052713]
  45. Diabetes. 2007 Jul;56(7):1761-72 [PMID: 17456850]
  46. Eur J Obstet Gynecol Reprod Biol X. 2019 Jun 08;3:100060 [PMID: 31403134]
  47. Nutrients. 2019 Jul 16;11(7): [PMID: 31315227]
  48. Front Endocrinol (Lausanne). 2020 May 27;11:284 [PMID: 32670195]
  49. BMC Med. 2023 Aug 9;21(1):302 [PMID: 37559119]
  50. Cell Metab. 2017 Jul 5;26(1):110-130 [PMID: 28625867]
  51. Free Radic Biol Med. 2017 Mar;104:165-177 [PMID: 28089725]
  52. J Funct Morphol Kinesiol. 2020 May 31;5(2): [PMID: 33467251]
  53. Nutrients. 2022 Aug 06;14(15): [PMID: 35956395]
  54. J Transl Med. 2020 Feb 27;18(1):104 [PMID: 32103756]
  55. ISME J. 2020 Jul;14(7):1897-1910 [PMID: 32341472]
  56. J Diabetes Metab Disord. 2021 Aug 4;20(2):1855-1870 [PMID: 34900829]
  57. Geburtshilfe Frauenheilkd. 2020 Feb;80(2):161-171 [PMID: 32109968]
  58. J Ovarian Res. 2019 Jan 21;12(1):5 [PMID: 30665436]
  59. Nat Med. 2012 Sep;18(9):1407-12 [PMID: 22863787]
  60. Diabetes Res Clin Pract. 2023 Aug;202:110803 [PMID: 37356723]
  61. Nature. 2016 Jul 21;535(7612):376-81 [PMID: 27409811]
  62. Br J Nutr. 2019 May;121(10):1097-1107 [PMID: 30834845]
  63. Maturitas. 2017 Sep;103:45-53 [PMID: 28778332]
  64. mSystems. 2019 Apr 16;4(2): [PMID: 31020040]
  65. Front Immunol. 2019 Nov 26;10:2653 [PMID: 31827467]
  66. J Transl Med. 2017 Apr 8;15(1):73 [PMID: 28388917]
  67. Hum Reprod. 2012 Feb;27(2):541-9 [PMID: 22144419]
  68. Nat Med. 2019 Aug;25(8):1225-1233 [PMID: 31332392]

Grants

  1. JJKH20230960KJ/The Science and Technology Project of the Jilin Provincial Department of Education

MeSH Term

Humans
Female
Gastrointestinal Microbiome
Polycystic Ovary Syndrome
Brain-Gut Axis
Immunity, Innate
Biological Transport

Word Cloud

Created with Highcharts 10.0.0microbiotagutPCOSaffectovaryobesitydevelopmentrecentcanmetabolismCurrentresearchhormonemetabolitesmayfunctionPolycysticsyndromeonemodernintractablereproductivediseasesfemaleirregularmenstruationinfertilityforthcausedbecomehotissueaffectingfamilyharmonysocialaetiologycomplexyearsmanyscholarsfoundpathogenesisrelatedimbalanceGutformtwo-waycommunicationbrain'gut-brainaxis'host'sconfirmedinterfereglucoselipidinsulinsensitivitysecretionfollicularwomenalteringintestinalmucosalpermeabilitysecretingadditiondiversitycompositionpatientschangedmetabolicabilityproducealsodirectlyindirectlyendocrinestudyreviewedadvancesroleorderprovidebasispreventiontreatmentbasedRoleinnateimmunitypolycysticsyndrome:updatesfutureprospects

Similar Articles

Cited By